Published in:
Open Access
01-02-2011 | Poster presentation
Use of statins in community-acquired pneumonia in intensive care settings: is there a survival advantage?
Authors:
A Khanna, R Gibbs, S Webster, H Al-shather
Published in:
Critical Care
|
Special Issue 1/2011
Login to get access
Excerpt
Use of statins in community-acquired pneumonia (CAP) and exacerbation of COPD has been widely studied [
1‐
3]. Whilst there may be some outcome benefit with the use of statins in exacerbation of COPD, their role in CAP remains less clear. There are no studies looking at outcome benefits from statin use in patients with CAP who are admitted to the intensive therapy unit (ITU). Therefore, we conducted a retrospective cohort analysis looking at statin use and outcomes in patients with CAP admitted to our ITU. …